Cargando…
Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy
Therapeutic approaches that engage immune cells to treat cancer are becoming increasingly utilized in the clinics and demonstrated durable clinical benefit in several solid tumor types. Most of the current immunotherapies focus on manipulating T cells, however, the tumor microenvironment (TME) is ab...
Autores principales: | Clappaert, Emile J., Murgaski, Aleksandar, Van Damme, Helena, Kiss, Mate, Laoui, Damya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186813/ https://www.ncbi.nlm.nih.gov/pubmed/30349530 http://dx.doi.org/10.3389/fimmu.2018.02250 |
Ejemplares similares
-
Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A’s: Abundance, Activation and Antigen-Delivery
por: Murgaski, Aleksandar, et al.
Publicado: (2019) -
Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment
por: Kiss, Máté, et al.
Publicado: (2022) -
Flt3L therapy increases the abundance of Treg-promoting CCR7(+) cDCs in preclinical cancer models
por: Clappaert, Emile J., et al.
Publicado: (2023) -
Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression
por: Laoui, Damya, et al.
Publicado: (2014) -
Mechanisms Driving Macrophage Diversity and Specialization in Distinct Tumor Microenvironments and Parallelisms with Other Tissues
por: Van Overmeire, Eva, et al.
Publicado: (2014)